COVID-19 molecular tests have already been authorized for individual use will have an easier time getting an FDA nod for pooled testing.
The FDA said today it will add tests by manufacturers who validated their nasal specimen test for pooling to its list of tests available for use with pooled nasal specimens. This could expand the number of tests that schools and employers can use to routinely screen asymptomatic individuals for SARS-CoV-2, the virus that causes COVID-19.
Get the full story on our sister site, Medical Design & Outsourcing.